PAHC
Phibro Animal Health Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares +6.2% ·
flujo de acciones +0.5% ·
nuevas posiciones netas +5.9%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | -15 | 15.40M | $484.24M | +5 | −22 |
| Q1 2026 | 95 | +6 | 14.51M | $800.97M | +11 | −5 |
| Q4 2025 | 89 | +1 | 14.47M | $540.64M | +1 | n/a |
| Q3 2025 | 17 | +1 | 9.22M | $372.92M | +1 | n/a |
| Q2 2025 | 13 | +1 | 8.13M | $207.65M | +2 | −1 |
| Q1 2025 | 9 | 0 | 3.02M | $64.46M | +1 | −1 |
| Q4 2024 | 9 | -1 | 3.00M | $62.94M | n/a | −1 |
| Q3 2024 | 9 | -1 | 1.81M | $40.65M | n/a | −1 |
| Q2 2024 | 10 | n/a | 1.66M | $27.80M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 3.43M | -1.9% | $138.62M | 0.0% | ▼ Trim | 2 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (pasivo) | 1.53M | -1.5% | $61.73M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasivo) | 894.04K | -1.7% | $36.17M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 597.55K | +902.7% | $24.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 5 | Renaissance Technologies ✦ | 555.20K | -9.1% | $22.46M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 547.16K | -1.4% | $22.14M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | JPMorgan Chase ✦ | 476.23K | n/a | $19.27M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 8 | Morgan Stanley ✦ | 436.04K | n/a | $17.64M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 9 | Arrowstreet Capital ✦ | 301.61K | +9.7% | $12.20M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 128.83K | n/a | $5.21M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 94.67K | +101.8% | $3.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 89.17K | -6.4% | $3.61M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 13 | Wellington Management ✦ | 71.51K | +8.2% | $2.89M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 14 | Citadel Advisors ✦ | 34.33K | -79.6% | $1.39M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 15 | T. Rowe Price ✦ | 17.12K | -6.0% | $693,000 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Millennium Management ✦ | 14.82K | -94.8% | $599,658 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 6.79K | Nuevo | $274,521 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Two Sigma Investments | $274,521 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 255 tenedores, 20.06M acciones, $1.03B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
48.2% de clase · Ver presentación original ante la SEC ↗